BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,400 | -70.4% | 10,663 | -53.1% | 0.02% | -40.0% |
| Q2 2023 | $1,361,177 | +144.2% | 22,730 | +202.5% | 0.03% | +25.0% |
| Q1 2023 | $557,408 | +85261.1% | 7,513 | -13.9% | 0.02% | +41.2% |
| Q4 2022 | $653 | -99.9% | 8,727 | -26.4% | 0.02% | -26.1% |
| Q3 2022 | $889,000 | +6.3% | 11,853 | +6.4% | 0.02% | -11.5% |
| Q2 2022 | $836,000 | -37.9% | 11,138 | -38.0% | 0.03% | +52.9% |
| Q1 2022 | $1,346,000 | +128.1% | 17,955 | +162.8% | 0.02% | +41.7% |
| Q4 2021 | $590,000 | +8.3% | 6,832 | +1.4% | 0.01% | +9.1% |
| Q3 2021 | $545,000 | +43.4% | 6,737 | +42.1% | 0.01% | +37.5% |
| Q2 2021 | $380,000 | +25.0% | 4,740 | +31.9% | 0.01% | +33.3% |
| Q1 2021 | $304,000 | -27.8% | 3,593 | -32.4% | 0.01% | -64.7% |
| Q4 2020 | $421,000 | -7.3% | 5,317 | -5.6% | 0.02% | -37.0% |
| Q3 2020 | $454,000 | -8.7% | 5,631 | -4.4% | 0.03% | -30.8% |
| Q2 2020 | $497,000 | -8.1% | 5,889 | -12.7% | 0.04% | -29.1% |
| Q1 2020 | $541,000 | +2.3% | 6,749 | +6.9% | 0.06% | +37.5% |
| Q4 2019 | $529,000 | -20.9% | 6,314 | -18.7% | 0.04% | -11.1% |
| Q3 2019 | $669,000 | +1238.0% | 7,765 | +1207.2% | 0.04% | +542.9% |
| Q1 2019 | $50,000 | -93.2% | 594 | -94.8% | 0.01% | -84.4% |
| Q4 2018 | $738,000 | -15.8% | 11,315 | -0.5% | 0.04% | +25.0% |
| Q3 2018 | $877,000 | +36.2% | 11,373 | +30.5% | 0.04% | +33.3% |
| Q2 2018 | $644,000 | +38.2% | 8,718 | +20.8% | 0.03% | +28.6% |
| Q1 2018 | $466,000 | 0.0% | 7,214 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $466,000 | -56.8% | 7,214 | -58.0% | 0.02% | -51.2% |
| Q3 2017 | $1,078,000 | +4.0% | 17,175 | +0.3% | 0.04% | -2.3% |
| Q2 2017 | $1,037,000 | +9.5% | 17,121 | -6.2% | 0.04% | +7.3% |
| Q1 2017 | $947,000 | +26.3% | 18,256 | +7.9% | 0.04% | +13.9% |
| Q4 2016 | $750,000 | -9.9% | 16,913 | -3.2% | 0.04% | -16.3% |
| Q3 2016 | $832,000 | +1.8% | 17,471 | -3.3% | 0.04% | -6.5% |
| Q2 2016 | $817,000 | +1534.0% | 18,075 | +2942.9% | 0.05% | +557.1% |
| Q1 2016 | $50,000 | -91.3% | 594 | -96.0% | 0.01% | -81.6% |
| Q4 2015 | $573,000 | – | 15,011 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |